Drug recall · February 5, 2025
Astagraf XL recall
Why: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.
- Lots / codes
Lot# 0R3092A, EXP 03/31/2026
- Quantity
- 3,500 30-count bottles
- Company
- Astellas Pharma US Inc., Northbrook, IL
- Distribution
- Nationwide in the USA
- Initiated
- December 23, 2024 · Voluntary: Firm initiated
- Classified
- January 29, 2025
- Reported
- February 5, 2025
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Astagraf
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.